Key result
MitraClip system implantation significantly improved real-time 3D global longitudinal strain from -9.8% at baseline to -11.0% at 1-month follow-up (P=0.018).
Why the study?
Does percutaneous mitral valve repair with the MitraClip system improve myocardial function measured by 3D-STE in patients with moderate-to-severe or severe mitral regurgitation?
Observational (n=30)
Does percutaneous mitral valve repair with the MitraClip system improve myocardial function measured by 3D-STE in patients with moderate-to-severe or severe mitral regurgitation?
MitraClip implantation for significant mitral regurgitation leads to early improvements in left ventricular deformation capability (global longitudinal strain) despite no significant early changes in standard volumetric parameters or ejection fraction.
Answers are grounded in this paper and cite their sources.
May reflect early myocardial recovery after MitraClip missed by EF; hypothesis-generating and requires prospective outcome trials.
AIMS: To appraise the early effect of percutaneous mitral valve repair with the MitraClip system on myocardial function using real-time three-dimensional speckle-tracking echocardiography (3D-STE). METHODS: Consecutive patients with moderate-to-severe or severe mitral regurgitation, undergoing mitral valve repair with the MitraClip system, were prospectively evaluated during the peri-procedural workout and follow-up. Left ventricular deformation was evaluated by a two-dimensional and 3D speckle-tracking analysis. 3D-STE acquisitions were elaborated obtaining real-time 3D global longitudinal strain evaluation, and by appraising both volumetric and hemodynamic parameters (i.e. left ventricular end-diastolic volume, left ventricular end-systolic volume, left ventricular ejection fraction, cardiac output, and stroke volume). RESULTS: In all, 30 patients were included. At 1-month follow-up, 3D-STE analysis revealed no changes in left ventricular end-diastolic volume (162.6 ± 73.7 ml at baseline vs. 159.8 ± 64.5 ml at 1-month follow-up; P = 0.63) and a downward trend in left ventricular end-systolic volume (104.7 ± 52.0 vs. 100.1 ± 50.4 ml, respectively; P = 0.06). Left ventricular ejection fraction did not significantly increase (38.1 ± 11.3% at baseline vs. 39.4 ± 11.0% at 1-month follow-up; P = 0.20). No significant changes were reported in cardiac output (4.3 ± 2.0 l/min at baseline vs. 4.0 ± 1.5 l/min at follow-up; P = 0.377) and in stroke volume (59.5 ± 25.5 ml at baseline vs. 59.9 ± 20.7 ml at follow-up; P = 0.867). On the contrary, left ventricular deformation capability significantly improved, with the real-time 3D global longitudinal strain value changing from -9.8 ± 4.1% at baseline to -11.0 ± 4.4% at follow-up (P = 0.018). CONCLUSIONS: Accurately assessing myocardial function by the use of 3D-STE, this study reported irrelevant early changes in left ventricular size, but a positive effect on left ventricular deformation capability following mitral valve repair with the MitraClip system. These preliminary results need to be confirmed in larger series and extended to long-term follow-up.
No takes yet. Share an insight, caveat, or question.
Scandura et al. (2015) conducted an observational in Moderate-to-severe or severe mitral regurgitation (n=30). MitraClip system implantation vs. Baseline was evaluated on Real-time 3D global longitudinal strain (p=0.018). MitraClip system implantation significantly improved real-time 3D global longitudinal strain from -9.8% at baseline to -11.0% at 1-month follow-up (P=0.018).
Synapse has enriched 10 related papers. Consider them for comparative context: